The Warburg effect and drug resistance B Bhattacharya, MF Mohd Omar, R Soong British journal of pharmacology 173 (6), 970-979, 2016 | 262 | 2016 |
Methodological aspects of whole-genome bisulfite sequencing analysis S Adusumalli, MF Mohd Omar, R Soong, T Benoukraf Briefings in bioinformatics 16 (3), 369-379, 2015 | 97 | 2015 |
Significance of immune checkpoint proteins in EGFR-mutant non-small cell lung cancer RA Soo, HR Kim, BR Asuncion, Z Fazreen, MFM Omar, MC Herrera, ... Lung Cancer 105, 17-22, 2017 | 56 | 2017 |
Characterization of Numb expression in astrocytomas B Yan, FM Omar, K Das, WH Ng, C Lim, K Shiuan, CT Yap, M Salto‐Tellez Neuropathology 28 (5), 479-484, 2008 | 51 | 2008 |
Cofilin immunolabelling correlates with depth of invasion in gastrointestinal endocrine cell tumors B Yan, CT Yap, S Wang, CK Lee, S Koh, MF Omar, M Salto-Tellez, ... Acta histochemica 112 (1), 101-106, 2010 | 33 | 2010 |
TRARESA: a tissue microarray-based hospital system for biomarker validation and discovery K Das, MF Mohd Omar, CW Ong, S Bin Abdul Rashid, BK Peh, TC Putti, ... Pathology 40 (5), 441-449, 2008 | 26 | 2008 |
Determinants of variability of five programmed death ligand-1 immunohistochemistry assays in non-small cell lung cancer samples RA Soo, JSY Lim, BR Asuncion, Z Fazreen, MC Herrera, MFM Omar, ... Oncotarget 9 (6), 6841, 2018 | 23 | 2018 |
Acquired resistance to PI3K/mTOR inhibition is associated with mitochondrial DNA mutation and glycolysis KX Koh, GH Tan, SHH Low, MFM Omar, MJ Han, B Iacopetta, R Soo, ... Oncotarget 8 (66), 110133, 2017 | 22 | 2017 |
RUNX3 Downregulation in Human Lung Adenocarcinoma is Independent of p53, EGFR or KRAS Status MFM Omar, K Ito, ME Nga, R Soo, BK Peh, TM Ismail, B Thakkar, R Soong, ... Pathology & Oncology Research 18, 783-792, 2012 | 14 | 2012 |
Molecular-assisted immunohistochemical optimization MFM Omar, N Huang, K Ou, K Yu, TC Putti, H Jikuya, T Ichikawa, ... Acta histochemica 112 (6), 519-528, 2010 | 12 | 2010 |
Lack of RUNX3 inactivation in columnar cell lesions of breast MM Subramaniam, JY Chan, MFM Omar, K Ito, Y Ito, KG Yeoh, ... Histopathology 57 (4), 555-563, 2010 | 12 | 2010 |
P2. 01-058 Mutational features associated with immunoreactivity in non-small cell lung cancer: topic: immune mechanisms in thoracic cancer and targeted therapy N Syn, D Tay, MFM Omar, JX Teo, J Lim, R Soo, R Soong Journal of Thoracic Oncology 12 (1), S821, 2017 | 7 | 2017 |
Effect of cell microenvironment on the drug sensitivity of hepatocellular cancer cells B Bhattacharya, DQ Huang, SHH Low, GH Tan, MJ Han, S Singh, B Tang, ... Oncotarget 12 (7), 674, 2021 | 4 | 2021 |
Whole exome sequencing of multi-regional biopsies from metastatic lesions to evaluate actionable truncal mutations using a single-pass percutaneous technique V Heong, D Tay, SE Goh, B Wee, TZ Tan, R Soo, B Pang, D Lim, ... Cancers 12 (6), 1599, 2020 | 3 | 2020 |
P3-010: Using immunohistochemistry to evaluate protein expression levels of female sex hormone receptors (ER, PR) and epidermal growth factor receptor family members (EGFR … ME Nga, MFM Omar, DG Lim, D Lim, CK Toh, R Soong, MS Tellez, ... Journal of Thoracic Oncology 2 (8), S502-S503, 2007 | 2 | 2007 |
Precision oncology: mind the disruption R Soong, N Syn, K Wang, MFM Omar Biochemist 38 (1), 14-18, 2016 | 1 | 2016 |
A novel in vitro microenvironment modeling platform for HCC therapeutics and biomarker development MFM Omar, B Tang, SC Chang, SHH Low, GH Tan, R Soong, ... Cancer Research 77 (13_Supplement), 165-165, 2017 | | 2017 |
Abstract B52: Bioenergetic switch confers acquired resistance to BEZ235 in EGFR T790M-mutant non-small cell lung cancer B Bhattacharya, KX Koh, MF Mohamed Omar, S Low, J Tan, NS Sapari, ... Molecular Cancer Therapeutics 14 (12_Supplement_2), B52-B52, 2015 | | 2015 |
Programmed death ligand-1 (PDL1) and CD3 co-expression in patients with advanced stage EGFR mutant NSCLC treated with EGFR tyrosine kinase inhibitors (TKI) RA Soo, HR Kim, BR Asuncion, Z Fazreen, MFM Omar, MC Herrera, ... Annals of Oncology 26, viii5, 2015 | | 2015 |
PD-L1 Expression in Tumor Infiltrating Immune Cells Determined by Digital Imaging Is Associated with Poor Survival in NSCLC Patients BGR Asuncion, Z Fazreen, MFM Omar, NLM Salleh, MA Rozario, ME Nga, ... JOURNAL OF THORACIC ONCOLOGY 10 (9), S600-S600, 2015 | | 2015 |